COPD GWAS variant at 19q13.2 in relation with DNA methylation and gene expression.
COPD GWAS variant at 19q13.2 in relation with DNA methylation and gene expression.
复制标题
DOI:
10.1093/hmg/ddx390
复制
发表时间:
2018-01-15
影响因子:
3.5
通讯作者:
Amin N
中科院分区:
文献类型:
--
作者:
Nedeljkovic I;Lahousse L;Carnero-Montoro E;Faiz A;Vonk JM;de Jong K;van der Plaat DA;van Diemen CC;van den Berge M;Obeidat M;Bossé Y;Nickle DC;Consortium BIOS;Uitterlinden AG;van Meurs JBJ;Stricker BHC;Brusselle GG;Postma DS;Boezen HM;van Duijn CM;Amin N
Chronic obstructive pulmonary disease (COPD) is among the major health burdens in adults. While cigarette smoking is the leading risk factor, a growing number of genetic variations have been discovered to influence disease susceptibility. Epigenetic modifications may mediate the response of the genome to smoking and regulate gene expression. Chromosome 19q13.2 region is associated with both smoking and COPD, yet its functional role is unclear. Our study aimed to determine whether rs7937 (RAB4B, EGLN2), a top genetic variant in 19q13.2 region identified in genome-wide association studies of COPD, is associated with differential DNA methylation in blood (N = 1490) and gene expression in blood (N = 721) and lungs (N = 1087). We combined genetic and epigenetic data from the Rotterdam Study (RS) to perform the epigenome-wide association analysis of rs7937. Further, we used genetic and transcriptomic data from blood (RS) and from lung tissue (Lung expression quantitative trait loci mapping study), to perform the transcriptome-wide association study of rs7937. Rs7937 was significantly (FDR < 0.05) and consistently associated with differential DNA methylation in blood at 4 CpG sites in cis, independent of smoking. One methylation site (cg11298343-EGLN2) was also associated with COPD (P = 0.001). Additionally, rs7937 was associated with gene expression levels in blood in cis (EGLN2), 42% mediated through cg11298343, and in lung tissue, in cis and trans (NUMBL, EGLN2, DNMT3A, LOC101929709 and PAK2). Our results suggest that changes of DNA methylation and gene expression may be intermediate steps between genetic variants and COPD, but further causal studies in lung tissue should confirm this hypothesis.
登录
查看更多内容
影响因子:
3.7
作者:
Lamontagne M;Couture C;Postma DS;Timens W;Sin DD;Paré PD;Hogg JC;Nickle D;Laviolette M;Bossé Y
通讯作者:
Bossé Y
影响因子:
16.6
作者:
Soler Artigas M;Wain LV;Miller S;Kheirallah AK;Huffman JE;Ntalla I;Shrine N;Obeidat M;Trochet H;McArdle WL;Alves AC;Hui J;Zhao JH;Joshi PK;Teumer A;Albrecht E;Imboden M;Rawal R;Lopez LM;Marten J;Enroth S;Surakka I;Polasek O;Lyytikäinen LP;Granell R;Hysi PG;Flexeder C;Mahajan A;Beilby J;Bossé Y;Brandsma CA;Campbell H;Gieger C;Gläser S;González JR;Grallert H;Hammond CJ;Harris SE;Hartikainen AL;Heliövaara M;Henderson J;Hocking L;Horikoshi M;Hutri-Kähönen N;Ingelsson E;Johansson Å;Kemp JP;Kolcic I;Kumar A;Lind L;Melén E;Musk AW;Navarro P;Nickle DC;Padmanabhan S;Raitakari OT;Ried JS;Ripatti S;Schulz H;Scott RA;Sin DD;Starr JM;UK BiLEVE;Viñuela A;Völzke H;Wild SH;Wright AF;Zemunik T;Jarvis DL;Spector TD;Evans DM;Lehtimäki T;Vitart V;Kähönen M;Gyllensten U;Rudan I;Deary IJ;Karrasch S;Probst-Hensch NM;Heinrich J;Stubbe B;Wilson JF;Wareham NJ;James AL;Morris AP;Jarvelin MR;Hayward C;Sayers I;Strachan DP;Hall IP;Tobin MD
通讯作者:
Tobin MD
影响因子:
3.5
作者:
Cho, Michael H.;Castaldi, Peter J.;Silverman, Edwin K.
通讯作者:
Silverman, Edwin K.
影响因子:
168.9
作者:
Gakidou, Emmanuela;Cowling, Krycia;Murray, Christopher J. L.
通讯作者:
Murray, Christopher J. L.
DOI:
10.1164/rccm.201403-0569oc
发表时间:
2014-08-15
影响因子:
24.7
作者:
Castaldi, Peter J.;Cho, Michael H.;Silverman, Edwin K.
通讯作者:
Silverman, Edwin K.